Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: an open-labeled clinical trial. - Wikidata - wikimedia - TriplyDB

Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: an open-labeled clinical trial.

Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: an open-labeled clinical trial.

http://www.wikidata.org/entity/Q33589769

about

Radiographic characteristics of the hand and cervical spine in fibrodysplasia ossificans progressiva High-throughput screening for modulators of ACVR1 transcription: discovery of potential therapeutics for fibrodysplasia ossificans progressiva.The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent.Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva.The Horizon of a Therapy for Rare Genetic Diseases: A "Druggable" Future for Fibrodysplasia Ossificans Progressiva.An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva

P2860

Q34377748-58249366-06FB-4221-B4EE-2A8E700B939A Q37036154-33B3A96D-6056-4CCF-9F2C-8F704C9FF90C Q47984195-2371B41B-0A5E-4075-A3D4-36301FD766C9 Q48009686-17FA8544-17F3-47FB-A548-82B1D97EAA20 Q52340220-152C62A8-0232-42A9-AD4A-E1252E073C19 Q58569719-BB96F6D2-E8DD-4D37-856F-D08EC61083F0

P2860

Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: an open-labeled clinical trial.

http://www.wikidata.org/entity/Q33589769

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Perhexiline maleate in the tre ...... n open-labeled clinical trial.

@ast

Perhexiline maleate in the tre ...... n open-labeled clinical trial.

@en

Perhexiline maleate in the tre ...... n open-labeled clinical trial.

@nl

type

label

Perhexiline maleate in the tre ...... n open-labeled clinical trial.

@ast

Perhexiline maleate in the tre ...... n open-labeled clinical trial.

@en

Perhexiline maleate in the tre ...... n open-labeled clinical trial.

@nl

prefLabel

Perhexiline maleate in the tre ...... n open-labeled clinical trial.

@ast

Perhexiline maleate in the tre ...... n open-labeled clinical trial.

@en

Perhexiline maleate in the tre ...... n open-labeled clinical trial.

@nl

P1433

Q33589769-8577F9BF-F18D-48B8-B9D8-DBE0A17D771B

P1476

Q33589769-E990B25B-1544-4476-BE8B-C49F22EA57FD

P2093

Q33589769-135095CB-5425-4E6B-B96B-C1AA0F6B9F07

Q33589769-525F2B57-5CDD-4065-9198-59E67AA27AA9

Q33589769-5C792219-206C-42D4-BDDA-DA00173B086F

Q33589769-60EBA978-AD4D-466B-A2A6-DD49E03C0A6E

Q33589769-793BCC93-17B0-4B97-8091-2CEA1C63F59E

Q33589769-C0F00137-3606-439E-BBA8-2664E1D8976B

Q33589769-D2C1CC92-C30C-4A63-B5D0-B9BAF922C0BB

Q33589769-EBB0138A-F449-455D-9719-D28CC798AC40

P2860

Q33589769-0C6CDE6E-46AE-4E2F-989C-91FD29FEDD30

Q33589769-2DF74DD6-F657-41B9-A78A-41C01CAA366D

Q33589769-4A5C529E-B236-475C-94E4-A56021BFE907

Q33589769-6671158E-62A1-4D20-8768-096630305FC4

Q33589769-83D5E0F2-ADDD-4390-B1CA-54F1A0BBF2F7

Q33589769-94F5249C-D463-4252-A7AC-2F64499B4E45

Q33589769-AC8E9B99-D78D-493B-99AC-F7B43AB2A6BD

Q33589769-C95673FE-EFBA-4A7C-BE41-57744E230309

Q33589769-E77870A3-66B2-45D3-83E5-0CA2C04F7E55

Q33589769-E7CD3E86-B72F-4D84-9295-D6F3B3E6B818

P2888

Q33589769-7069141F-F23C-45A2-9B2E-19014D61BA9E

P304

Q33589769-0E784683-5662-4571-B881-14029CB59CFE

P31

Q33589769-02E60F97-1FFB-461C-B6F0-18F9858C662C

P356

Q33589769-3ED423B7-221E-4623-AEE7-E3A3CFA31631

P478

Q33589769-D1F98D94-4E11-4D90-A7F8-74A605935AA0

P50

Q33589769-22FEF4E1-8754-497F-89FD-6FC83EE9133C

Q33589769-A227C81B-A467-40DC-9E87-46B87E3586A8

P577

Q33589769-D018D0EA-B4E3-40C6-8CEB-FDDD20AF3031

P5875

Q33589769-9A292671-CF14-43BA-B9AC-C0363ED803E0

P6179

Q33589769-2D15ABCA-5AEA-4637-B86E-FB387E21DBDD

P698

Q33589769-522F4C9A-F5B7-486E-96B4-094A0C43A483

P921

Q33589769-CAAAFDB1-7416-475E-B4EF-24BA4406C0D2

P932

Q33589769-2B8DD1AB-EDBF-4F2B-813B-3F7D1C641EF1

P356

1750-1172-8-163

P1433

Orphanet Journal of Rare Diseases

P1476

Perhexiline maleate in the tre ...... n open-labeled clinical trial.

@en

P2093

Benedetta C Sallustio

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kaneko

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kitoh

http://www.w3.org/2001/XMLSchema#string

Izumi Kadono

http://www.w3.org/2001/XMLSchema#string

Kenichi Mishima

http://www.w3.org/2001/XMLSchema#string

Masaki Matsushita

http://www.w3.org/2001/XMLSchema#string

Masataka Achiwa

http://www.w3.org/2001/XMLSchema#string

Naoki Ishiguro

http://www.w3.org/2001/XMLSchema#string

P2860

A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva

BMP type I receptor inhibition reduces heterotopic [corrected] ossification

Impaired oxidation of debrisoquine in patients with perhexiline neuropathy

Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism

Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis

Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists.

Fibrodysplasia ossificans progressiva: clinical and genetic aspects

Fibrodysplasia ossificans progressiva

Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva.

Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice.

P2888

1750-1172-8-163

P304

163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1750-1172-8-163

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257888296

http://www.w3.org/2001/XMLSchema#string

P6179

1051913220

http://www.w3.org/2001/XMLSchema#string

P698

24131551

http://www.w3.org/2001/XMLSchema#string

P921

fibrodysplasia ossificans progressiva

P932

4015865

http://www.w3.org/2001/XMLSchema#string